hotspot -WSS

hotspot

author：explore 2025-08-28 08:39:46 - browse：26

Cambridge: AbbVie — Ruby Wallau for STAT

AbbVie will pay $10 billion for the biotech firm Immunogen, the company said Thursday, acquiring an approved treatment for ovarian cancer and buying into a burgeoning area of oncology.

Under the agreement, AbbVie will pay $31.26 per share in cash for Immunogen, a nearly 100% premium to the company’s recent trading price. Central to the deal, expected to close in the middle of next year, is Elahere, an Immunogen product that won Food and Drug Administration approval for advanced ovarian cancer in 2022.

Elahere is among a surging class of cancer medicines called antibody-drug conjugates, or ADCs, which are designed to deliver a targeted dose of chemotherapy directly to tumor cells while sparing healthy tissues. AbbVie’s acquisition is the latest multibillion-dollar deal in the space, following Merck’s $22 billion agreement with ADC specialist Daiichi Sankyo and Pfizer’s $43 billion buyout of Seagen earlier this year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Celiac disease study examines precisely how gluten triggers injury

WSS

WuXi Biologics execs register to lobby as Congress comes for the company

Eli Lilly to acquire Versanis in heated race for weight loss drugs

Everything to know for the next Powerball drawing as jackpot hits $1 billion

Eli Lilly to acquire Versanis in heated race for weight loss drugs

Medicare eyes cuts to doctors, raises to outpatient clinics in 2024

What a koala virus tells us about the human genome

entertainment

hotspot

knowledge

23andMe had bad news about my health. I wish a person had delivered it

4 killed in mass shooting in Georgia, shooter remains on the loose: Police

Medicare proposal to cover medical devices draws a mixed reaction

Manchin, Huntsman team up to talk platform for 'unity' ticket that could run in 2024

Supreme Court strikes down use of affirmative action

Manchin, Huntsman team up to talk platform for 'unity' ticket that could run in 2024

In Memoriam: Notable people who died in 2023

Does aspartame cause cancer? What new WHO guidance says

Trump demands the U.S. pay no more for drugs than other countries … again

J&J expands global access to TB drug amid advocacy campaign

leisure time

Oak Street deal isn't the answer to health care's woes

Argenx drug significantly slows progression of nerve disorder

As H5N1 spreads in cows, experts warn against drinking raw milk

WuXi Biologics execs register to lobby as Congress comes for the company

Global childhood vaccinations edge closer to pre

To spot an incipient stroke, tiny brain probe acts ‘like a microscope’

hotspot

explore

leisure time

hotspot